PeptiDream is reported to have obtained approval for the site of a new plant for radiopharmaceuticals. The specific location and details of the approval are not provided in the article.
Approval has been reported for the site of a new radiopharmaceutical plant associated with PeptiDream. The article focuses on the approval news and does not include additional information such as the plant's location or investment scale.
Formal announcements and further disclosures are awaited. At this stage, the article avoids definitive statements about the background to the approval and future development plans.